Ferreira Filho, A F <br/><br/>
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Mar 2002 
 - 416-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdf051  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Belgium<br/>Breast Neoplasms--drug therapy<br/>Cyclophosphamide--therapeutic use<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Feasibility Studies<br/>Female<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Lymph Nodes--pathology<br/>Lymphatic Metastasis<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Postmenopause<br/>Premenopause